Transfusion-Associated Graft-Versus-Host Disease

254 จิรายุ เอื้อวรากุลrecipients. Transf Med Review 1996;10: 31-43.22. Yasuura K, Okamoto H, Matsuura A. Transfusionassociatedgraft-versus-host disease with transfusionpractice in cardiac surgery. J Cardiovasc Surg (Torino)2000; 41:377-80.23. Wagner FF, Flegel WA. Transfusion-associated graftversus-hostdisease: risk due to homozygous HLAhaplotypes. Transfusion 1995;35:284-91.24. Ito K, Fujita M, Norioka M, Yoshida H, Arii S, TanakaJ, Tobe T, Kakuyama M, Maruya E, Saji H. Postoperative erythroderma with change of HLA phenotypesfrom heterozygotes to homozygotes: a report of twocases. European J Haematology 1991;46: 217-22.25. Benson K, Marks AR, Marshall MJ, Goldstein JD.Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous plateletsfrom unrelated donors. Transfusion 1994;34: 432-7.26. Nishimura M, Uchida S, Mitsunaga S, Yahagi Y,Nakajima K, Tadokoro K, Juji T. Characterization of T-cell clones derived from peripheral blood lymphocytesof a patient with transfusion-associated graft-versushostdisease: Fas-mediated killing by CD4+ and CD8+cytotoxic T-cell clones and tumor necrosis factor betaproduction by CD4+ T-cell clones. Blood 1997;89:1440-5.27. Brubaker DB. Transfusion-associated graft-versus-hostdisease. Human Pathology 1986;17: 1085-8.28. Hentschel R, Broecker EB, Kolde G. Intact survivalwith transfusion-associated graft-versus-host diseaseproved by human leukocyte antigen typing of lymphocytes in skin biopsy specimens. J Pediatrics 1995;126:61-4.29. Sale GE, Shulman HM, Hackman RC. Pathology ofhematopoieticcelltransplantation. In:HematopoieticCell Transplantation. ED Thomas, KG Blume, SJForman, eds. Oxford,UK: Blackwell Science 1999:248-63.30. DrobyskiW,ThibodeauS,TruittRL,Baxter-LoweLA,Gorski J, Jenkins R, Gottschall J, Ash RC. Thirdpartymediatedgraft rejection and graft-versus-hostdisease after T-cell depleted bone marrow transplantation,asdemonstratedbyhypervariableDNAprobesand HLA-DR polymorphism. Blood 1989;74:2285-94.31. Hayakawa S, Chishima F, Sakata H, Fujii K, Ohtani K,Kurashina K, Hayakawa J, Suzuki K, Nakabayashi H,Esumi M, Nemoto N, Sakurai I, Satoh K. A rapidmolecular diagnosis of posttransfusion graft-versushostdisease by polymerase chain reaction. Transfusion1993;33:413-7.32. Kunstmann E, Bocker T, Roewer L, Sauer H, MempelW, Epplen JT. Diagnosis of transfusion-associatedgraftversus-host disease by genetic fingerprinting andpolymerase chain reaction. Transfusion 1992;32: 766-70.33. Lee TH, Donegan E, Slichter S, Busch MP. Transientincrease in circulating donor leukocytes after allogeneictransfusions in immunocompetent recipients compatible with donor cell proliferation. Blood 1995;85:1207-14.34. Douglas SD, Fudenberg HH. Graft- versus-host reactionin Wiskott-Aldrich syndrome: antemortem diagnosis ofhuman GVH in an immunologic deficiency disease.Vox Sanguinis 1969;16:172-8.35. Ohto H, Anderson KC. Post-transfusion graft-versushost disease in Japanese newborns. Transfusion1996a;36:117-23.36. Prince M, Szer J, van der Weyden MB, Pedersen JS,Holdsworth RF, Whyte G. Transfusion associated graftversus-hostdisease after cardiac surgery: response toantithymocyte-globulin and corticosteroid therapy.Australian and New Zealand J Med 1991;21: 43-6.37. Ryo R, Saigo K, Hashimoto M, Kohsaki M, Yasufuku M,Watanabe N, Okada M, Tadokoro K, Juji T. Treatmentof post-transfusion graft-versus-host disease withnafmostat mesilate, a serine protease inhibitor. VoxSanguinis 1999;76:241-6.38. Przepiorka D, Kernan NA, Ippoliti C, Papadopoulos EB,GiraltS,KhouriI,LuJG,GajewskiJ,DurettA,ClearyK, Champlin R, Andersson BS, Light S. Daclizumab,ahumanized anti-interleukin-2 receptor alpha chainantibody, for treatment of acute graft-versus-hostdisease. Blood 2000;95:83-9.39. Luban NL. Prevention of transfusion-associated graftversus-hostdisease by inactivation of T cells inThai Journal of Hematology and Transfusion Medicine Vol. 12 No. 3 June-September 2002